BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 2, 2007
View Archived Issues
Hana Biosciences presents new data on compounds utilizing its Optisome technology
Read More
Medivir presents third quarter 2007 results
Read More
Recent patents describe novel agents for anxiety, psychosis and sleep disorders
Read More
New antiglaucoma agents reported in recent Allergan patent
Read More
Recent Ranbaxy patent discloses new therapeutic agents for urinary incontinence
Read More
CAM-24 shows antipsychotic activity in vivo with low potential for motor side effects
Read More
SNAP25 may be a common susceptibility gene for ADHD and early-onset bipolar affective disorder
Read More
European Commission grants marketing authorization for Nexavar
Read More
The Hsp90 inhibitor NVP-AUY-922 profiled at the AACR-NCI-EORTC meeting
Read More
Epix reports positive results from phase IIb clinical trial of PRX-07034 in obesity
Read More
Peptech successfully completes phase I trial for PN-0621
Read More
Results of BEYOND study in Betaferon do not support regulatory filing for 500 mcg dose
Read More
Pharming completes randomized treatments in clinical trial of Rhucin
Read More
TST-10088 well tolerated in ongoing phase I study
Read More
Favorable results seen in phase I study of XMT-1001
Read More
Threshold updates corporate activities and clinical development
Read More
Relypsa formed as a spin-out company of Amgen and Ilypsa
Read More
Battelle acquires the assets of Ventaira Pharmaceuticals
Read More
Eli Lilly and Glenmark enter license agreement for GRC-6211
Read More
Adherex initiates collaborative phase III trial of sodium thiosulfate
Read More
Forbes Medi-Tech close to compound selection in FM-TP2000 and FM-TP3000 series
Read More
Sciele and Plethora initiate patient enrollment in phase III trials of PSD-502
Read More
Nycomed to acquire Bradley Pharmaceuticals
Read More
Inovio and Tripep begin enrollment of patients for phase I/II clinical trial of ChronVac-C
Read More
Bayer HealthCare submits rivaroxaban MAA to the EMEA
Read More
Meda submits NDA for BEMA Fentanyl to FDA
Read More
FDA approves Allergan's Combigan for reduction of intraocular pressure
Read More
Results from phase III registration trial of satraplatin fail to achieve statistical significance
Read More
U.K. grants marketing authorization to Javelin's Dyloject for acute pain
Read More